SIGA Technologies: Edison Open House Healthcare 2022

SIGA Technologies: Edison Open House Healthcare 2022

SIGA Technologies is a commercial-stage health security company focused on the treatment of smallpox and other orthopoxviruses. It has contracts with both the US and Canadian governments for TPOXX, its treatment for smallpox.

• Please provide a brief overview of SIGA Technologies and its unusual model.
• Has the current pandemic further highlighted the advantages of having these solutions on standby?
• How does the G7 100-day strategy help the company?
• What do you think the global addressable market opportunity is currently and how would your label expansions increase it?
• Is the potential for smallpox escaping from a lab a genuine risk?
• Which milestones should investors look out for over the next six to 12 months?


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free